Dumont & Blake Investment Advisors LLC Takes Position in Intuitive Surgical, Inc. $ISRG

Dumont & Blake Investment Advisors LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 395 shares of the medical equipment provider’s stock, valued at approximately $215,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Chilton Capital Management LLC raised its stake in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares during the period. Elite Financial Inc. acquired a new stake in Intuitive Surgical during the first quarter worth about $26,000. LFA Lugano Financial Advisors SA acquired a new stake in Intuitive Surgical during the first quarter worth about $30,000. TD Capital Management LLC raised its stake in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares during the period. Finally, 1248 Management LLC acquired a new stake in Intuitive Surgical during the first quarter worth about $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $446.13 on Friday. The stock has a market capitalization of $159.93 billion, a price-to-earnings ratio of 62.22, a PEG ratio of 4.69 and a beta of 1.61. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company has a 50 day moving average price of $454.97 and a 200 day moving average price of $495.75.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm’s revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period last year, the firm posted $1.78 earnings per share. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on ISRG. Truist Financial dropped their price objective on shares of Intuitive Surgical from $600.00 to $525.00 and set a “buy” rating on the stock in a research note on Wednesday. Robert W. Baird decreased their target price on shares of Intuitive Surgical from $600.00 to $536.00 and set an “outperform” rating for the company in a research report on Wednesday. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday. Royal Bank Of Canada restated an “outperform” rating and issued a $615.00 target price on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Finally, Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $580.29.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 335 shares of the firm’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares in the company, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 45,224 shares of company stock worth $21,716,492. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.